InnoSIGN
Eindhoven, Netherlands· Est.
We are passionate to bring to market our OncoSIGNal pathway activity profiling technology contributing to a better understanding of disease mechanisms in oncology. OncoSIGNal enables next generation precision medicine by translating molecular data into functional cell behavior.
Private Company
Total funding raised: $7M
About
We are passionate to bring to market our OncoSIGNal pathway activity profiling technology contributing to a better understanding of disease mechanisms in oncology. OncoSIGNal enables next generation precision medicine by translating molecular data into functional cell behavior.
Diagnostics
Funding History
2Total raised:$7M
Series A$5.5M
Seed$1.5M